![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/evelos-voyage-ends-flagship-founded-biotech-finds-dissolution-only-viable-option
https://www.globenewswire.com//news-release/2023/10/17/2761342/0/en/Evelo-Biosciences-Announces-Top-Line-Results-From-its-Phase-2-Clinical-Study-with-EDP2939-in-Moderate-Psoriasis.html
https://www.globenewswire.com/news-release/2023/08/14/2724292/0/en/Evelo-Biosciences-Announces-Second-Quarter-Financial-Results-and-Recent-Business-Highlights.html
https://seekingalpha.com/article/4623796-circling-back-on-evelo-biosciences
https://seekingalpha.com/news/3989500-evelo-biosciences-enters-into-termination-and-surrender-pact-with-bio-rad
https://www.globenewswire.com/news-release/2023/07/12/2703423/0/en/Evelo-Biosciences-Closes-25-5-Million-Private-Placement.html
https://www.globenewswire.com/news-release/2023/07/10/2701677/0/en/Evelo-Biosciences-Announces-25-5-Million-Private-Placement.html
https://www.globenewswire.com/news-release/2023/06/29/2697068/0/en/Evelo-Biosciences-Announces-Reverse-Stock-Split-Effective.html
https://www.globenewswire.com/news-release/2023/04/26/2654930/0/en/Evelo-Biosciences-Provides-Clinical-Updates.html